UniProt ID | PHAG1_RAT | |
---|---|---|
UniProt AC | Q9JM80 | |
Protein Name | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 | |
Gene Name | Pag1 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 424 | |
Subcellular Localization |
Cell membrane Single-pass type III membrane protein . Present in lipid rafts. |
|
Protein Description | Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins. May be involved in cell adhesion signaling.. | |
Protein Sequence | MGPAGSALSSGQMQMQMVLWGSLAAVAMFFLITFLILLCSSCDRDKKPRQHSGDHESLMNVPSDKEMFSHSATSLTTDALASSEQNGVLTNGDILSEDSTMTCMQHYEEVQTSASDLLDSQDSTGKAKCHQSRELPRIPPENAVDAMLTARAADGDSGPGVEGPYEVLKDSSSQENMVEDCLYETVKEIKEVADKSQGGKSKSTSALKELQGAHAEGKADFAEYASVDRNKKCRHSTNAESILGTSSDLDEETPPPVPVKLLDENANLPEKGEHGAEEQAPEAPSGHSKRFSSLSYKSREEDPTLTEEEISAMYSSVNKPGQSAHKPGPESTCQCPQGPPQRSSSSCNDLYATVKDFEKTPNSISMLPPARRPGEEPEPDYEAIQTLNREDDKVPLGTNGHLVPKENDYESIGDLQQGRDVTRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
39 | S-palmitoylation | ITFLILLCSSCDRDK HHHHHHHHHHCCCCC | 2.23 | - | |
42 | S-palmitoylation | LILLCSSCDRDKKPR HHHHHHHCCCCCCCC | 2.60 | - | |
52 | Phosphorylation | DKKPRQHSGDHESLM CCCCCCCCCCHHHHH | 37.26 | 27097102 | |
57 | Phosphorylation | QHSGDHESLMNVPSD CCCCCHHHHHCCCCC | 29.51 | 27097102 | |
63 | Phosphorylation | ESLMNVPSDKEMFSH HHHHCCCCCHHHHHC | 57.96 | 22673903 | |
107 | Phosphorylation | TMTCMQHYEEVQTSA CCHHHHHHHHHHHCH | 9.26 | 16920712 | |
157 | Phosphorylation | ARAADGDSGPGVEGP HHHCCCCCCCCCCCC | 53.03 | 27097102 | |
165 | Phosphorylation | GPGVEGPYEVLKDSS CCCCCCCHHHHCCCC | 29.53 | 27097102 | |
171 | Phosphorylation | PYEVLKDSSSQENMV CHHHHCCCCCCCCHH | 30.24 | 27097102 | |
172 | Phosphorylation | YEVLKDSSSQENMVE HHHHCCCCCCCCHHH | 46.29 | 27097102 | |
173 | Phosphorylation | EVLKDSSSQENMVED HHHCCCCCCCCHHHH | 45.53 | 27097102 | |
183 | Phosphorylation | NMVEDCLYETVKEIK CHHHHHHHHHHHHHH | 18.84 | 27097102 | |
185 | Phosphorylation | VEDCLYETVKEIKEV HHHHHHHHHHHHHHH | 24.26 | 27097102 | |
201 | Phosphorylation | DKSQGGKSKSTSALK HHHCCCCCHHHHHHH | 34.80 | 25575281 | |
203 | Phosphorylation | SQGGKSKSTSALKEL HCCCCCHHHHHHHHH | 34.38 | 25575281 | |
204 | Phosphorylation | QGGKSKSTSALKELQ CCCCCHHHHHHHHHH | 23.04 | 25575281 | |
205 | Phosphorylation | GGKSKSTSALKELQG CCCCHHHHHHHHHHH | 38.40 | 25575281 | |
224 | Phosphorylation | GKADFAEYASVDRNK CCCCHHHHHCCCCCC | 10.76 | 27097102 | |
226 | Phosphorylation | ADFAEYASVDRNKKC CCHHHHHCCCCCCCC | 24.53 | 29779826 | |
236 | Phosphorylation | RNKKCRHSTNAESIL CCCCCCCCCCHHHHH | 12.19 | 27097102 | |
237 | Phosphorylation | NKKCRHSTNAESILG CCCCCCCCCHHHHHC | 32.11 | 27097102 | |
241 | Phosphorylation | RHSTNAESILGTSSD CCCCCHHHHHCCCCC | 22.24 | 27097102 | |
245 | Phosphorylation | NAESILGTSSDLDEE CHHHHHCCCCCCCCC | 22.93 | 27097102 | |
246 | Phosphorylation | AESILGTSSDLDEET HHHHHCCCCCCCCCC | 21.76 | 27097102 | |
247 | Phosphorylation | ESILGTSSDLDEETP HHHHCCCCCCCCCCC | 41.87 | 27097102 | |
253 | Phosphorylation | SSDLDEETPPPVPVK CCCCCCCCCCCCCCE | 38.76 | 27097102 | |
292 | Phosphorylation | SGHSKRFSSLSYKSR CCCCCCCCCCCCCCC | 34.11 | 27097102 | |
293 | Phosphorylation | GHSKRFSSLSYKSRE CCCCCCCCCCCCCCC | 20.72 | 27097102 | |
295 | Phosphorylation | SKRFSSLSYKSREED CCCCCCCCCCCCCCC | 32.25 | 27097102 | |
296 | Phosphorylation | KRFSSLSYKSREEDP CCCCCCCCCCCCCCC | 20.48 | 27097102 | |
298 | Phosphorylation | FSSLSYKSREEDPTL CCCCCCCCCCCCCCC | 36.37 | 27097102 | |
304 | Phosphorylation | KSREEDPTLTEEEIS CCCCCCCCCCHHHHH | 59.64 | 30181290 | |
306 | Phosphorylation | REEDPTLTEEEISAM CCCCCCCCHHHHHHH | 43.77 | 30181290 | |
311 | Phosphorylation | TLTEEEISAMYSSVN CCCHHHHHHHHHHCC | 15.40 | 30181290 | |
314 | Phosphorylation | EEEISAMYSSVNKPG HHHHHHHHHHCCCCC | 9.49 | 10918051 | |
315 | Phosphorylation | EEISAMYSSVNKPGQ HHHHHHHHHCCCCCC | 18.09 | 30181290 | |
316 | Phosphorylation | EISAMYSSVNKPGQS HHHHHHHHCCCCCCC | 16.54 | 30181290 | |
323 | Phosphorylation | SVNKPGQSAHKPGPE HCCCCCCCCCCCCCC | 37.95 | - | |
343 | Phosphorylation | PQGPPQRSSSSCNDL CCCCCCCCCCCCHHH | 29.35 | 27097102 | |
344 | Phosphorylation | QGPPQRSSSSCNDLY CCCCCCCCCCCHHHH | 28.58 | 27097102 | |
345 | Phosphorylation | GPPQRSSSSCNDLYA CCCCCCCCCCHHHHH | 39.91 | 27097102 | |
346 | Phosphorylation | PPQRSSSSCNDLYAT CCCCCCCCCHHHHHH | 20.91 | 21738781 | |
351 | Phosphorylation | SSSCNDLYATVKDFE CCCCHHHHHHHHHHH | 11.77 | 27097102 | |
381 | Phosphorylation | GEEPEPDYEAIQTLN CCCCCCCHHHHHHCC | 20.27 | 27097102 | |
386 | Phosphorylation | PDYEAIQTLNREDDK CCHHHHHHCCCCCCC | 21.64 | 27097102 | |
409 | Phosphorylation | LVPKENDYESIGDLQ CCCCCCCCCCCCCHH | 24.13 | 27097102 | |
411 | Phosphorylation | PKENDYESIGDLQQG CCCCCCCCCCCHHCC | 26.16 | 27097102 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
107 | Y | Phosphorylation | Kinase | LYN | Q07014 | Uniprot |
314 | Y | Phosphorylation | Kinase | FYN | Q62844 | Uniprot |
314 | Y | Phosphorylation | Kinase | LYN | P25911 | PSP |
314 | Y | Phosphorylation | Kinase | LYN | Q07014 | Uniprot |
314 | Y | Phosphorylation | Kinase | SRC | Q9WUD9 | PSP |
381 | Y | Phosphorylation | Kinase | LYN | P25911 | PSP |
409 | Y | Phosphorylation | Kinase | LYN | P25911 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHAG1_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHAG1_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Csk-binding protein mediates sequential enzymatic down-regulation anddegradation of Lyn in erythropoietin-stimulated cells."; Ingley E., Schneider J.R., Payne C.J., McCarthy D.J., Harder K.W.,Hibbs M.L., Klinken S.P.; J. Biol. Chem. 281:31920-31929(2006). Cited for: INTERACTION WITH LYN AND CSK, AND PHOSPHORYLATION AT TYR-107 ANDTYR-314. | |
"Transmembrane phosphoprotein Cbp positively regulates the activity ofthe carboxyl-terminal Src kinase, Csk."; Takeuchi S., Takayama Y., Ogawa A., Tamura K., Okada M.; J. Biol. Chem. 275:29183-29186(2000). Cited for: PHOSPHORYLATION AT TYR-165; TYR-183; TYR-224; TYR-314; TYR-381 ANDTYR-409, AND FUNCTION. | |
"Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases."; Kawabuchi M., Satomi Y., Takao T., Shimonishi Y., Nada S., Nagai K.,Tarakhovsky A., Okada M.; Nature 404:999-1003(2000). Cited for: NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION BY MASS SPECTROMETRY,INTERACTION WITH CSK, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,MUTAGENESIS OF TYR-107; TYR-165; TYR-183; TYR-224; TYR-296; TYR-314;TYR-351; TYR-381 AND TYR-409, PHOSPHORYLATION AT TYR-314, ANDFUNCTION. |